Benitec Biopharma Stock (NASDAQ: BNTC) stock price, news, charts, stock research, profile.
Open | $6.570 |
Close | $6.860 |
Volume / Avg. | 26.465K / 78.969K |
Day Range | 6.570 - 7.040 |
52 Wk Range | 1.860 - 9.010 |
Market Cap | $18.199M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 67 |
Short Interest | 0.57% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Benitec Biopharma (NASDAQ: BNTC) through any online brokerage.
Other companies in Benitec Biopharma’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN) and Dominari Holdings (NASDAQ:DOMH).
The latest price target for Benitec Biopharma (NASDAQ: BNTC) was reported by JMP Securities on Monday, April 22, 2024. The analyst firm set a price target for 16.00 expecting BNTC to rise to within 12 months (a possible 127.92% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Benitec Biopharma (NASDAQ: BNTC) is $7.02 last updated April 22, 2024 at 5:14 PM EDT.
There are no upcoming dividends for Benitec Biopharma.
Benitec Biopharma’s Q3 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Benitec Biopharma.
Benitec Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.